Carumonam

Carumonam
Clinical data
Trade namesAmasulin
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • 2-[(Z)-[1-(2-Amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-(carbamoyloxymethyl)-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxyacetic acid
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H14N6O10S2
Molar mass466.40 g·mol−1
3D model (JSmol)
  • C1=C(N=C(S1)N)/C(=N/OCC(=O)O)/C(=O)N[C@H]2[C@H](N(C2=O)S(=O)(=O)O)COC(=O)N
  • InChI=1S/C12H14N6O10S2/c13-11-15-4(3-29-11)7(17-28-2-6(19)20)9(21)16-8-5(1-27-12(14)23)18(10(8)22)30(24,25)26/h3,5,8H,1-2H2,(H2,13,15)(H2,14,23)(H,16,21)(H,19,20)(H,24,25,26)/b17-7-/t5-,8+/m1/s1 checkY
  • Key:UIMOJFJSJSIGLV-JNHMLNOCSA-N checkY
 X markNcheckY (what is this?)  (verify)

Carumonam (INN) is a monobactam antibiotic previously sold in Japan under the brand name Amasulin. One of only four members of its class, Carumonam was withdrawn sometime before 2021, leaving only Aztreonam on the market. It is very resistant to beta-lactamases, which means that it is more difficult for bacteria to break down using β-lactamase enzymes.